News

Oktober 16 | 2009

SAVIRA AMONG THE MOST PROMISING VIENNA START-UP COMPANIES

Savira was awarded third place by the City of Vienna Future Award

September 23 | 2009

FOUNDATION OF SAVIRA PHARMACEUTICALS GMBH

Savira, an Austrian pharmaceutical company focusing on the development of novel anti-influenza drugs was recently established in Vienna and supported with seed financing of 1 Mio Euro by the AWS (Austria Wirtschaftsservice). Based on intellectual property from the co-founders, the European Molecular Biology Laboratory (EMBL) from Heidelberg, Germany and the biotech company onepharm from Vienna, Austria, Savira will manage a medicinal chemistry program aiming at the identification of lead candidates and the development of anti-influenza drugs.